Blood inflammation markers may predict obesity complications

NCT ID NCT07431593

First seen Mar 04, 2026 · Last updated May 01, 2026 · Updated 5 times

Summary

This study will check if two blood inflammation markers (SII and SIRI) can help predict metabolic problems like insulin resistance and fatty liver in 200 adults with overweight or obesity. Participants will have body measurements, blood tests, and diet checkups, and be followed for 3 years to see how they respond to weight-loss treatments. The goal is to find a simple way to identify those at higher risk and guide better care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.